During the past decade, Specialty Care Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specialty Care Research" are "Benign Prostatic Hyperplasia" (1 trials), "Preneoplastic Conditions" (1 trials), "Prostatic Intraepithelial Neoplasia" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Specialty Care Research" in a lesser frequency.

Most popular intervention types in "Specialty Care Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Leuprolide acetate" (1 trials), "Lonidamine" (1 trials), "Placebo" (1 trials) and "Toremifene 20 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specialty Care Research" are 3 trials for "Male" genders.

Currently, there are NaN active trials in "Specialty Care Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Specialty Care Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Specialty Care Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".